Gazyva (obinutuzumab)

pCPA File Number: 21082
Negotiation Status:
Negotiations were not pursued
Indication(s):
Follicular lymphoma, Relapsed or refractory
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0126-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: